Skip to main content
. 2010 May 28;3(1):11–18. doi: 10.1007/s12308-010-0059-3

Table 3.

Frequency of EBV-positive Hodgkin Lymphoma in adults in different regions/continents of the world

  cHL (%) NS (%) MC (%) LD (%) NLPHL (%) TOTAL (%)
Mediterranean Countries, Middle East
 Tunisia 2002 [4] 72 69 87 100 0 70
 Turkey 2008 [5] 91 61
 Saudi Arabia 2001 [6] 56 56 56
 Kuwait 2003[7] 60 34 79 100 25 56
 Egypt 1996 [8] 60 67 57 0 50 50
 Saudi Arabia 1998 [9] 54 47 88 0 47
 Jordan 2004 [10] 47 29 60 0 47
 Israel 1997 [11] 30 22 45 30
 Jordan 2004 [12] 28 19 57 28
East Africa
 Kenya 1996 [13] 94 87 100 100 0 92
 Kenya 1998 [14] 80 57 85 80 67 79
 Kenya 1996 [15] 67 69 100 50 33 68
 Kenya 1997 [16] 44
Central and South America
 Peru 1993 [17] 84 100 100 50 84
 Mexico 1995 [18] 70 50 81 86 70
 Mexico 1995 [19] 69 46 100 83 0 67
 Argentina 1994-2004 [20] 52 50 62 0 52
 Puerto Rico 2003 [21] 50 50
 Costa Rica 1998 [22] 43 15 86 100 0 40
 Argentina 2003 [23] 32 24 39 100 0 31
Asia
 India 2003 [24] 82 86 82
 Korea 1996 [25] 70 59 74 64 57 69
 Taiwan 1998 [26] 67 64 69 100 0 66
 Japan 1996 [27] 64 44 84 64
 Japan 1998 [14] 56 36 67 71 67 58
 Malaysia 1997 [28] 61 33 92 50 0 51
 Taiwan 2008 [29] 50 50
 China 2001 [30] 39 25 64 0 0 39
Europe
 Greece 1996 [8] 89 92 86 100 91
 Switzerland 1992 [31] 79 79
 Italy 1996 [13] 58 45 92 100 0 56
 Germany 1992 [32] 48 41 55 50 100 49
 Bosnia 2007 [33] 48 48
 Hungary 2006 [34] 43 35 50 43
 Spain 2000 [35] 41 41
 France 1992 [36] 39 10 60 0 35
 U.K. 1994 [37] 33 44 35 33
 Belgium 2007 [38] 33
 UK 2003 [39] 33 24 60 33
 UK 1993 [40] 37 24 68 14 0 32
 Sweden 1999 [41] 27 23 38 100 20 27
USA and Australia
 USA 1989 [42] 68 57 92 100 0 65
 USA 1994 [43] 47 27 77 47
 USA 2004 [12] 30 14 75 30
 USA 1994 [44] 28 14 69 66 0 25
 Australia 1996 [8] 73 73 100 0 69

For each country, the first column shows the number (n°) of cases studied whereas the other columns show the percentages of positive cases. For each region of the world, the countries have been organized according to the percentage of positive cases studied, from the highest to the lowest. For each series, the reference for the publication is given after the year of publication

– absence of case, 0 no EBV-positive case